Download Files:
BCR-ABL-IN-2
SKU
HY-18819-Get quote
Category Reference compound
Tags Bcr-Abl, Cancer, Protein Tyrosine Kinase/RTK
Products Details
Product Description
– BCR-ABL-IN-2 is an inhibitor of BCR-ABL1 tyrosine kinase, with IC50s of 57 nM, 773 nm for ABL1native and ABL1T315I, respectively.
Web ID
– HY-18819
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C24H25Cl2N5O3
References
– [1]Chan WW, et al. Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036. Cancer Cell. 2011 Apr 12;19(4):556-68.|[2]ARYL SULFONOHYDRAZIDES. US 2008/0113967 A1.
CAS Number
– 897369-18-5
Molecular Weight
– 502.39
SMILES
– O=C([C@H]1NCC2=C(C=C(N3N=C(C(C)(C)C)C=C3NC(NC4=CC=CC(Cl)=C4Cl)=O)C=C2)C1)O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Bcr-Abl
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.